Oscar Health, Inc. (OSCR) ended the recent trading session at $16.28, demonstrating a -0.12% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.92% for the day. At the same time, the Dow added 0.31%, and the tech-heavy Nasdaq gained 2.03%.
Prior to today's trading, shares of the company had gained 20.03% over the past month. This has outpaced the Finance sector's gain of 4.35% and the S&P 500's gain of 0.81% in that time.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to go public on February 4, 2025. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.58 per share. This would mark year-over-year growth of 12.12%. Meanwhile, the latest consensus estimate predicts the revenue to be $2.46 billion, indicating a 71.91% increase compared to the same quarter of the previous year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. presently features a Zacks Rank of #3 (Hold).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 21.31. This indicates a premium in contrast to its industry's Forward P/E of 9.98.
We can also see that OSCR currently has a PEG ratio of 0.65. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Insurance - Multi line stocks are, on average, holding a PEG ratio of 1.09 based on yesterday's closing prices.
The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 89, putting it in the top 36% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oscar Health, Inc. (OSCR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.